Improving Advance Care Planning by Preparing Diverse Seniors for Decision Making (PREPARE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01990235|
Recruitment Status : Unknown
Verified May 2016 by University of California, San Francisco.
Recruitment status was: Recruiting
First Posted : November 21, 2013
Last Update Posted : May 24, 2016
|Condition or disease||Intervention/treatment||Phase|
|Chronic Disease||Behavioral: PREPARE Intervention||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||500 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Primary Purpose:||Supportive Care|
|Official Title:||Improving Advance Care Planning by Preparing Diverse Seniors for Decision Making|
|Study Start Date :||January 2013|
|Estimated Primary Completion Date :||March 2018|
|Estimated Study Completion Date :||June 2018|
Experimental: PREPARE intervention
The PREPARE arm will review the PREPARE website plus the easy-to-read advance directive (AD). Participants will review PREPARE on their own for ≥ 20 minutes with staff present to answer questions. During PREPARE, participants answer preference questions and make an action plan (i.e., commitment to engage in advance care planning). To ensure home access to PREPARE content, participants will be given a website login and PREPARE content in digital video disc (DVD), booklet, and pamphlet format as well as the action plan and AD. One to three days before a primary care visit, the PREPARE arm will receive a reminder to come to their appointment and to bring their action plan.
Behavioral: PREPARE Intervention
At week 1, 3, 6, and 12 months, interviews (telephone or in person based on preference) by blinded staff will assess engagement in advance care planning(ACP), self-efficacy with ACP, and activation in and satisfaction with decision making. Blinded telephone interviews will also assess surrogate reports of patient engagement in ACP.
No Intervention: Control
The Control arm will review an easy-to-read AD. Controls will review the AD for ≥ 15 minutes with study staff present to answer questions and will take the AD home to complete if desired. One to three days before a primary care visit, controls will receive a reminder to come to their appointment.
- Change in engagement in advance care planning behavior using validated surveys at 12 months from baseline [ Time Frame: 12 months from baseline ]
Engagement in 5 behaviors that is a composite outcome of ACP engagement.
- Advance Directive completion - An advance directive form, a living will, a durable power of attorney for health care, Physicians Orders of Life Sustaining Treatment, or other documentation, such as code status.
- Advance care planning discussions with surrogates - Asking someone to be a surrogate, talking about goals for medical care, whether to grant leeway, or discussions relating to medical decision making or prognosis.
- Advance care planning discussions with clinicians - Discussions concerning a surrogate, goals for medical care, whether to grant surrogates leeway, or discussions relating to medical decision making or prognosis.
- Inform others (friends/family member identified as important) - Discussions about advance care planning-related topics
- Ask doctors questions - risks, benefits, options.
These behaviors will be measured using validated surveys on a 1 to 5 scale.
- Change in advance care planning behavior at 12 months from baseline [ Time Frame: 12 months from baseline ]
Investigators will measure the following, which will be extracted from one validated survey:
- Advance care planning behavior change
- Self-efficacy with advance care planning behaviors
- Engagement in medical decision making
- Satisfaction with medical decision making
- Surrogate-reports of patient engagement in advance care planning
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01990235
|Contact: Rebecca Sudore, MD||415-221-4810 ext email@example.com|
|Contact: Mariko Feuz, BS||415-221-4810 ext firstname.lastname@example.org|
|United States, California|
|San Francisco General Hospital and Trauma Center||Recruiting|
|San Francisco, California, United States, 94110|
|Contact: Rebecca Sudore, MD 415-221-4810 ext 3475 email@example.com|
|Contact: Mariko Feuz, BS 415-221-4810 ext 25922 Mariko.firstname.lastname@example.org|
|Principal Investigator: Rebecca Sudore, MD|
|Principal Investigator:||Rebecca Sudore, MD||University of California, San Francisco|
|Principal Investigator:||Dean Schillinger, MD||University of California, San Francisco|
|Principal Investigator:||Deborah E Barnes, PhD||University of California, San Francisco|
|Principal Investigator:||W. John Boscardin, PhD||San Francisco Veteran Affairs Medical Center|